Exhibitor

Veracyte is a leading genomic diagnostics company providing actionable tests for lung cancer and idiopathic pulmonary fibrosis. Since 2008, the company has developed genomic tests to fundamentally improve patient care when current diagnostic tests are uncertain. Veracyte’s products uniquely combine genomic technology, clinical science and machine learning to provide answers that give physicians and patients a clear path forward without risky, costly procedures that are often unnecessary. For more information, please visit www.veracyte.com.